| Title |
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
|
|---|---|
| Published in |
Diabetologia, July 2009
|
| DOI | 10.1007/s00125-009-1440-6 |
| Pubmed ID | |
| Authors |
C. J. Currie, C. D. Poole, E. A. M. Gale |
| Abstract |
The risk of developing a range of solid tumours is increased in type 2 diabetes, and may be influenced by glucose-lowering therapies. We examined the risk of development of solid tumours in relation to treatment with oral agents, human insulin and insulin analogues. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 13% |
| Japan | 1 | 13% |
| Unknown | 6 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 452 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| Italy | 3 | <1% |
| Spain | 3 | <1% |
| United Kingdom | 3 | <1% |
| Germany | 2 | <1% |
| Netherlands | 2 | <1% |
| South Africa | 2 | <1% |
| Ireland | 1 | <1% |
| Hong Kong | 1 | <1% |
| Other | 6 | 1% |
| Unknown | 426 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 79 | 17% |
| Student > Ph. D. Student | 65 | 14% |
| Student > Master | 54 | 12% |
| Student > Bachelor | 47 | 10% |
| Other | 34 | 8% |
| Other | 112 | 25% |
| Unknown | 61 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 207 | 46% |
| Agricultural and Biological Sciences | 51 | 11% |
| Biochemistry, Genetics and Molecular Biology | 32 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 4% |
| Chemistry | 9 | 2% |
| Other | 58 | 13% |
| Unknown | 79 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2022.
All research outputs
#1,309,701
of 26,017,215 outputs
Outputs from Diabetologia
#702
of 5,621 outputs
Outputs of similar age
#3,758
of 127,659 outputs
Outputs of similar age from Diabetologia
#4
of 51 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,621 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,659 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.